Company Performance - Wuxi Jinghai's stock price reached a historical high, increasing by 11.70% to 30.93 yuan, with a trading volume of 4.2815 million shares and a transaction amount of 123 million yuan, resulting in a turnover rate of 12.03% [2] - The latest total market capitalization of Wuxi Jinghai in A-shares is 2.403 billion yuan, with a circulating market value of 1.101 billion yuan [2] - The company reported a revenue of 203 million yuan for the first half of the year, representing a year-on-year growth of 18.67%, and a net profit of 37.3014 million yuan, up 34.77% year-on-year, with basic earnings per share of 0.4800 yuan and a weighted average return on equity of 5.51% [2] Industry Overview - The pharmaceutical and biotechnology industry, to which Wuxi Jinghai belongs, experienced an overall decline of 0.61%, with 77 stocks rising and 3 stocks hitting the daily limit, while 416 stocks fell [2] - The stocks with the largest declines in the industry include Sairui Medical, Duolai Pharmaceutical, and Shutaishen, with declines of 8.86%, 8.38%, and 8.11% respectively [2] Margin Trading Data - As of September 1, the latest margin trading balance for Wuxi Jinghai was 12.408 million yuan, with a financing balance of 12.408 million yuan, reflecting an increase of 1.8925 million yuan over the past 10 days, which is a growth of 18.00% [2]
无锡晶海股价创新高，融资客抢先加仓